Expression of epidermal growth factor receptor in benign and malignant primary tumours of the breast
✍ Scribed by M�ller, P. ;Mechtersheimer, G. ;Kaufmann, M. ;Moldenhauer, G. ;Momburg, F. ;Mattfeldt, T. ;Otto, H. F.
- Publisher
- Springer-Verlag
- Year
- 1989
- Tongue
- English
- Weight
- 923 KB
- Volume
- 414
- Category
- Article
- ISSN
- 0174-7398
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The prognostic value of epidermal growth factor receptor (EGFR) expression and its biological role in estrogen receptorpositive (ER+) and ER-negative (ER-) primary breast cancer is controversial. In this study, distributions of ER, progesterone receptor and EGFR have been established using immunohis
Background. Gestational trophoblastic neoplasms comprise the neoplastic spectrum of nonmalignant hydatidiform mole, invasive hydatidiform mole, and truly malignant choriocarcinoma. Increasing evidence indicates that epidermal growth factor (EGF) acts as an enhancer of trophoblast function to produce
Bearing in mind the continuing controversy over the prognostic significance of epidermal growth factor receptor (EGF-r) expression, we investigated its clinical significance prospectively in 345 primary breast cancer patients. The prognostic significance of EGF-r expression, as measured by a radioli